EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multilineage cells from human adipose tissue: implications for cell-based therapies



Multilineage cells from human adipose tissue: implications for cell-based therapies



Tissue Engineering 7(2): 211-228



Future cell-based therapies such as tissue engineering will benefit from a source of autologous pluripotent stem cells. For mesodermal tissue engineering, one such source of cells is the bone marrow stroma. The bone marrow compartment contains several cell populations, including mesenchymal stem cells (MSCs) that are capable of differentiating into adipogenic, osteogenic, chondrogenic, and myogenic cells. However, autologous bone marrow procurement has potential limitations. An alternate source of autologous adult stem cells that is obtainable in large quantities, under local anesthesia, with minimal discomfort would be advantageous. In this study, we determined if a population of stem cells could be isolated from human adipose tissue. Human adipose tissue, obtained by suction-assisted lipectomy (i.e., liposuction), was processed to obtain a fibroblast-like population of cells or a processed lipoaspirate (PLA). These PLA cells can be maintained in vitro for extended periods with stable population doubling and low levels of senescence. Immunoflourescence and flow cytometry show that the majority of PLA cells are of mesodermal or mesenchymal origin with low levels of contaminating pericytes, endothelial cells, and smooth muscle cells. Finally, PLA cells differentiate in vitro into adipogenic, chondrogenic, myogenic, and osteogenic cells in the presence of lineage-specific induction factors. In conclusion, the data support the hypothesis that a human lipoaspirate contains multipotent cells and may represent an alternative stem cell source to bone marrow-derived MSCs.

(PDF same-day service: $19.90)

Accession: 035349307

Download citation: RISBibTeXText

PMID: 11304456

DOI: 10.1089/107632701300062859



Related references

Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research 332(3): 415-426, 2008

Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 25(4): 818-827, 2007

Influence of standardized 3D-cell-culture on multilineage differentiation of human adipose tissue derived stem cells. Journal of Stem Cells & Regenerative Medicine 2(1): 119-119, 2007

Successful isolation of viable adipose-derived stem cells from human adipose tissue subject to long-term cryopreservation: positive implications for adult stem cell-based therapeutics in patients of advanced age. Stem Cells International 2015: 146421-146421, 2015

Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Research & Therapy 1(2): 19-19, 2010

Bone differentiation and formation using adipose tissue-derived stromal cells for cell-based therapies. Boei Ika Daigakko Zasshi 32(4): 186-197, 2007

Mesenchymal stem cells derived from bone marrow and human adipose tissue exhibit multilineage potential. Journal of Investigative Medicine 48(1): 95A, January, 2000

Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplantation 22(5): 779-795, 2013

Human adipose tissue-derived multilineage progenitor cells exposed to oxidative stress induce neurite outgrowth in PC12 cells through p38 MAPK signaling. Bmc Cell Biology 13(): 21-21, 2013

Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies. Tissue Engineering. Part A 16(4): 1143-1155, 2010

Transplantation of human adipose tissue-derived multilineage progenitor cells reduces serum cholesterol in hyperlipidemic Watanabe rabbits. Tissue Engineering. Part C, Methods 17(2): 145-154, 2011

HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits. Biochemical and Biophysical Research Communications 412(1): 50-54, 2011

Multilineage cells from adipose tissue as gene delivery vehicles. Human Gene Therapy 14(1): 59-66, 2003

Multilineage co-culture of adipose-derived stem cells for tissue engineering. Journal of Tissue Engineering and Regenerative Medicine 9(7): 826-837, 2016